Sullivan Wood Capital Management LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,434 shares of the healthcare conglomerate's stock, valued at approximately $447,000. UnitedHealth Group makes up about 0.9% of Sullivan Wood Capital Management LLC's investment portfolio, making the stock its 15th biggest holding.
A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the period. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group during the first quarter worth $42,000. Kentucky Trust Co boosted its stake in UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock worth $45,000 after buying an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC boosted its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of recent analyst reports. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research note on Friday, September 12th. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $358.95.
Check Out Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock opened at $353.26 on Friday. The company has a market capitalization of $319.94 billion, a PE ratio of 15.31, a P/E/G ratio of 2.27 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50-day simple moving average of $306.25 and a two-hundred day simple moving average of $356.57. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is presently 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.